Profiles of Drug Substances, Excipients and Related Methodology

Dr. Brittain is presently the Institute Director of the Center for Pharmaceutical Physics, a research and consulting institute he established in 1999 for the study of substances having pharmaceutical interest. His research interest include all areas of pharmaceutical physics and physical pharmacy, including preformulation, formulation design, product characterization, polymorphism, solvatomorphism, and cocrystals of drug substances. Formerly, Dr. Brittain was Vice President for Pharmaceutical Development of Discovery Laboratories, Inc., he served as Director of Pharmaceutical Development at Ohmeda, Inc., and also led a variety of groups within the Analytical R&D department at Bristol-Myers Squibb. Dr. Brittain is a graduate of Queens College (B.A. in chemistry, 1970; M.A. in physical chemistry 1972), and of the City University of New York (Ph.D. in physical chemistry, 1975). He was a postdoctoral fellow at the University of Virginia, and has held full-time faculty positions at Ferrum College (Assistant Professor of Chemistry) and Seton Hall University (Associate Professor of Physical and Inorganic Chemistry). He has been Adjunct Professor of Pharmaceutics at Rutgers University, and both Adjunct Professor of Chemistry and Visiting Research Scientist at Lehigh University. Dr. Brittain has authored over 340 research publications and book chapters, and has presented over 175 invited lectures and short courses in the pharmaceutical field. He has edited the monographs Analytical Applications of Circular Dichroism, Physical Characterization of Pharmaceutical Solids, Polymorphism in Pharmaceutical Solids (first and second editions), Spectroscopy of Pharmaceutical Solids, and Preformulation in Solid Dosage Form Development. He is also the Editor-In-Chief of the book series Profiles of Drug Substances, Excipients, and Related Methodology, having edited 23 published volumes in the series that is now published annually by Elsevier. Dr. Brittain is also an Editor of Physical

1. Cinnarizine: Comprehensive Profile
Nadia G. Haress
2. Glutathione
Amer M. Alanazi, Gamal A.E. Mostafa and Abdullah A. Al-Badr
3. Losartan: Comprehensive Profile
Abdul-Rahman A. Al-Majed, Ebrahim Assiri, Nasr Y. Khalil and Hatem A. Abdel-Aziz
4. Prasugrel Hydrochloride
Mahmoud M.H. Al Omari, Nidal A. Qinna, Iyad S. Rashid, Khaldoun A. Al-Sou'od and Adnan A. Badwan
5. Salmeterol Xinafoate
Manal M. Anwar, Radwan S. El-Haggar and Wafaa A. Zaghary
6. Telmisartan
Ahmed H. H. Bakheit, Ahmed A. Abd-Elgalil, Bakheit Mustafa, Anzarul Haque and Tanveer A. Wani
7. Valsartan
Febry Ardiana, Suciati and Gunawan Indrayanto